Nipecotic Acid CAS 498-95-3 Hale Hana Maʻemaʻe Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa Kemika: Nipecotic Acid

CAS: 498-95-3

Nānā: Keʻokeʻo a Melemele Crystalline Powder

ʻIke: ≥98.0% (TLC)

Kūlana Kiʻekiʻe, Hana Kūʻai

Inquiry: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia ʻAka Nipecotic
Nā huaʻōlelo like DL-Nipecotic Acid;3-Piperidinecarboxylic Acid;H-DL-Nip-OH
Helu CAS 498-95-3
Helu CAT RF-PI284
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala C6H11NO2
Kaumaha Molecular 129.16
Hiki i ka wai Hiki i ka wai
Kūlana Hoʻouna Hoʻouna ʻia ma lalo o ka wela ambient
Brand ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Keokeo a Melemele Crystalline pauda
Decompose Mahana ≥261.0 ℃
ʻIkepili IR, NMR
Nalo ma ka maloo ≤1.0%
Koena ma ka Ignition ≤1.0%
Hana ʻIke / ʻIke ≥98.0% (TLC)
Kūlana hoʻāʻo ʻOihana Kūlana;Pākē Pharmacopoeia (CP)
Hoʻohana Nā Kūwaena Lapaʻau

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

1

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o Nipecotic Acid (CAS: 498-95-3) me ke kūlana kiʻekiʻe, hoʻohana nui ʻia i ka synthesis organik, synthesis o nā intermediates pharmaceutical a me Active Pharmaceutical Ingredient (API) synthesis.ʻO ka ʻakika Nipecotic (CAS: 498-95-3) he mea hiki ke hoʻopaʻa i ka lawe ʻana o ka γ-aminobutyric acid (GABA) i nā ʻāpana lolo ʻiole.Hoʻohana ʻia nā lipophilic derivatives o ka waikawa nipecotic e like me nā lāʻau lapaʻau no ka mālama ʻana i ka epilepsy.
Palapala noi
Ua hoʻohana ʻia ka waikawa Nipecotic i ka hoʻoholo ʻana i ka lāʻau antiepileptic vigabatrin a me nā neurotransmitters amino acid i loko o ka lolo ʻiole extracellular fluid e ka capillary;electrophoresis me ka laser-induced fluorescence detection;Reactant no ka esterification concurrent a me N-acteylation o nā waikawa amino me nā orthoesters
Reactant no ka synthesis o:
Nā lāʻau anticonvulsant:HCV NS5B polymerase inhibitors;ʻO nā mea hoʻopaneʻe Cathepsin S;ʻO nā mea kūʻē P2Y12 bioavailable waha no ka pale ʻana i ka platelet aggregation;ʻO ka modulator allosteric maikaʻi o ka metabotropic glutamate receptor 4

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou